Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06525974
EARLY_PHASE1

Clinical Study to Evaluate the Possible Efficacy and Safety of Febuxostat in Patients With Ulcerative Colitis Treated With Mesalamine

Sponsor: Tanta University

View on ClinicalTrials.gov

Summary

Evaluation the possible efficacy and safety of febuxostat in patients with ulcerative colitis treated with mesalamine.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

46

Start Date

2024-09-01

Completion Date

2026-12-30

Last Updated

2024-07-29

Healthy Volunteers

No

Interventions

DRUG

Febuxostat

40mg of Febuxostat once daily

DRUG

Mesalamine

1 g mesalamine three times daily for 3 months.